PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsRamosetron
Ramosetron
Ramosetron is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
66 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
VomitingD014839—R11.1—3491935
NauseaD009325—R11.0—3461427
Postoperative nausea and vomitingD020250EFO_0004888——2191022
SyndromeD013577——123219
Irritable bowel syndromeD043183EFO_0000555K58—23218
DiarrheaD003967—R19.7—22217
NeoplasmsD009369—C80—11114
Ambulatory surgical proceduresD000556—————1—1
Bone fracturesD050723EFO_0003931T14.8———1—1
FaciesD019066—————1—1
Show 3 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovarian neoplasmsD010051EFO_0003893C56—11——2
Stomach neoplasmsD013274EFO_0003897C16——1——1
LeiomyomaD007889—D25——1——1
AdenomyosisD062788EFO_1001757N80.0——1——1
MyofibromaD047708————1——1
Fecal incontinenceD005242—R15—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149—G89.18—1——34
Ovarian epithelial carcinomaD000077216———1———1
Lung neoplasmsD008175—C34.90—1———1
Hematologic neoplasmsD019337———1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———2————2
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypotensionD007022EFO_0005251I95————22
ElectroacupunctureD015671——————11
Colorectal neoplasmsD015179——————11
Rotator cuff injuriesD000070636—M75.1————11
ShiveringD012768——————11
Laparoscopic cholecystectomyD017081——————11
HysteroscopyD015907——————11
Prostatic neoplasmsD011471—C61————11
Coronary artery bypassD001026EFO_0003776—————11
Colonic neoplasmsD003110—C18————11
Show 2 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameRamosetron
INNramosetron
Description
Ramosetron is a member of indoles.
Classification
Small molecule
Drug classserotonin 5-HT3 receptor antagonists
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21
Identifiers
PDB—
CAS-ID132036-88-5
RxCUI—
ChEMBL IDCHEMBL1643895
ChEBI ID—
PubChem CID108000
DrugBank—
UNII ID7ZRO0SC54Y (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,093 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
44 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use